Lucid Diagnostics Inc.

LUCD | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.89

+$0.04 (+5.31%)

At close: Sep 22, 2026, 4:00 PM ET

$0.87

-$0.02 (-2.79%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.31%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $170.28M

1D Range

0.84 0.91

52W Range

0.75 1.63

Valuation (TTM)

PE -1.81

PB 14.75

EV/EBITDA -2.97

Valuation (NTM)

Forward PE N/A

Forward PEG 0.06

Price Target $2

Cash Flow

FCF Yield -29.3%

SBC Adj. FCF Yield -1454.7%

SBC Impact -4870.5%

Margins

Gross Margin -25.8%

Operating Margin -930.9%

FCF Margin -866.6%

Growth (CAGR)

Revenue 3Y | 5Y 90.1% | 43.4%

Dil EPS 3Y | 5Y 41.5% | 18.2%

FCF 3Y | 5Y -4.6% | -12.9%

Returns

ROA -134.2%

ROE -404.3%

ROIC -141.4%

Financial Health

Net Cash

$9.9M

Current Ratio 1.33

Interest Coverage -2,815.83

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux diseas...

Sector Healthcare

Industry Medical - Devices

Employees 82

IPO Date Oct 13, 2021

Website www.luciddx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+124.72%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞